Olopatadine Hydrochloride
규격
140462-76-6CAS 번호
604-185-4EC 번호
2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid;hydrochlorideIUPAC 명칭
C21H24ClNO3화학식
373.9 g/mol분자량
OLOPATADINE HYDROCHLORIDE; 140462-76-6; OLOPATADINE HCl; Pataday; Allelock; Patanase; Pazeo; ALO4943A; KW4679; DTXSID0046486; ALO-4943A; KW-4679; Olopatadine (as hydrochloride); 2XG66W44KF; DTXCID8026486; Dibenz(b,e)oxepin-2-acetic acid, 11-(3-(dimethylamino)propylidene)-6,11-dihydro-, hydrochloride, (Z)-; RYALTRIS COMPONENT OLOPATADINE HYDROCHLORIDE; Retaine Allergy; Once Daily Relief; RefChem:56800; Eye Allergy Itch Relief; Hydrochloride, Olopatadine; CVS Eye Allergy Itch Relief; Olopatadine Hydrochloride Nasal; PATADAY ONCE DAILY RELIEF; KW4943A; PATADAY TWICE DAILY RELIEF; PATADAY TWICE A DAY RELIEF; KW 4943A; Olopatadine Hydrochloride Ophthalmic; Eye Allergy Itch and Redness Relief; EQUATE OLOPATADINE HYDROCHLORIDE; LEADER OLOPATADINE HYDROCHLORIDE; CVS Eye Allergy Itch Relief Once Daily; 4679, KW; CVS Eye Allergy Itch Relief Twice Daily; Eye Allergy Itch Relief Once Daily Relief; Olopatadine Hydrochloride Ophthalmic Solution; Rugby Olopatadine Hydrochloride Ophthalmic Solution; Equate Olopatadine Hydrochloride Ophthalmic Solution; Leader Olopatadine Hydrochloride Ophthalmic Solution; Eye Allergy Itch and Redness Relief Twice Daily Relief; Olopatadine Hydrochloride Ophthalmic Solution Once Daily; Olopatadine Hydrochloride Ophthalmic Solution Twice Daily; Olopatadine Hydrochloride Ophthalmic Solution Once Daily Relief; 11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid; (11-((1Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenzo(b,e)oxepin-2-yl)acetic acid monohydrochloride; Patanol; MFCD00875716; (Z)-2-(11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid hydrochloride; Dibenz[b,e]oxepin-2-acetic acid, 11-[3-(dimethylamino)propylidene]-6,11-dihydro-, hydrochloride (1:1), (11Z)-; Olopatadine (hydrochloride); Olopine; Patadine; Olopax; CHEMBL1719; KW 4679; CAS-140462-76-6; Opatanol (TN); 2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid;hydrochloride; UNII-2XG66W44KF; SR-01000763388; Opatanol;; Pataday;; Patanol;; ALO 4943A; Olopatadine hydrochloride [USAN]; Patanol S;; Allelock (TN); (Z)-2-(11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-yl)aceticacidhydrochloride; (Z)-2-[11-[3-(Dimethylamino)propylidene]-6,11-dihydrodibenzo[b,e]oxepin-2-yl]acetic Acid Hydrochloride; Patanol (TN); DE 114; Olopatadine hydrochloride [USAN:USP]; Olopatadine Hydrochlorde; O-PPDS; NCGC00164623-01; SCHEMBL23213; MLS001401465; HY-B0426AR; orb1309531; SCHEMBL29381853; SCHEMBL29402772; CHEBI:31933; HY-B0426A; AL4943A; ALO4943A;KW4679; GLXC-05220; HMS5081C13; EX-A1347; MSK14403A-100M; Olopatadine hydrochloride (Opatanol); Tox21_112242; EBC-07851; EBC-11262; Olopatadine HCl - Bio-X trade mark; s2494; OLOPATADINE HYDROCHLORIDE [MI]; AKOS015895232; AKOS025149118; Olopatadine hydrochloride (JP18/USP); Tox21_112242_1; CCG-101141; FO29183; KS-1228; NC00391; Olopatadine (hydrochloride) (Standard); OLOPATADINE HYDROCHLORIDE [JAN]; NCGC00263532-01; OLOPATADINE HYDROCHLORIDE [MART.]; OLOPATADINE HYDROCHLORIDE [VANDF]; 11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid hydrochloride; 11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid, hydrochloride; BO164171; Dibenz(b,e)oxepin-2-acetic acid, 11-(3-dimethylamino)propylidene)-6,11-dihydro-, hydrochloride, (Z)-; OLOPATADINE HYDROCHLORIDE [USP-RS]; OLOPATADINE HYDROCHLORIDE [WHO-DD]; SMR000469220; SY072625; Olopatadine hydrochloride, >=98% (HPLC); OLOPATADINE HYDROCHLORIDE [EMA EPAR]; O0361; O4658; C72607; D01192; OLOPATADINE HYDROCHLORIDE [ORANGE BOOK]; OLOPATADINE HYDROCHLORIDE [USP MONOGRAPH]; EN300-19652056; EN300-25953569; F876095; SR-01000763388-4; Q27255766; Olopatadine hydrochloride Solution in Methanol, 100ug/mL; Z2568665949; Olopatadine hydrochloride, United States Pharmacopeia (USP) Reference Standard; (11Z)-11-[3-(Dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid hydrochloride; {(11Z)-11-[3-(Dimethylamino)propylidene]-6,11-dihydrodibenzo[b,e]oxepin-2-yl}acetic acid--hydrogen chloride (1/1); 2-[(2Z)-2-[3-(dimethylamino)propylidene]-9-oxatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-5-yl]acetic acid hydrochloride; 2-{2-[3-(dimethylamino)propylidene]-9-oxatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-5-yl}acetic acid hydrochloride동의어
Olopatadine Hydrochloride 함유 제품
올로비드엠점안액0.2%(올로파타딘염산염)(1회용)알파데이점안액0.7%(올로파타딘염산염)(1회용)올로벨라0.7에스디점안액(올로파타딘염산염)(1회용)올로타딘점안액0.2%(올로파타딘염산염)(1회용)올로루체점안액0.7%(올로파타딘염산염)(1회용)파라딘0.2%점안액(올로파타딘염산염)(수출용)파라딘점안액(올로파타딘염산염)(수출용)휴로타딘점안액0.7%(올로파타딘염산염)파타젠점안액(올로파타딘염산염)(1회용)파타딘점안액0.7%(올로파타딘염산염)(1회용)올로닉스점안액0.7%(올로파타딘염산염)(1회용)올로닉스점안액0.2%(올로파타딘염산염)(1회용)
1/16 페이지
Olopatadine Hydrochloride 판매 기업
한미
한미약품(주)Republic of Korea(주
(주)휴온스Republic of Korea(주
(주)유한양행Republic of Korea한림
한림제약(주)Republic of Korea(주
(주)대웅제약Republic of Korea환인
환인제약(주)Republic of Korea아주
아주약품(주)Republic of Korea(주
(주)넥스팜코리아Republic of Korea유니
유니메드제약(주)Republic of Korea광동
광동제약(주)Republic of Korea1/10 페이지